Spring 2012
Promise is published three times a year by The University of Texas MD Anderson Cancer Center and is dedicated to our friends who have joined us in Making Cancer History®.
Goal to speed drug discovery and development
Demos T. Kyrazis, Ph.D., lives in Albuquerque, N.M. Following his third retirement in 1993, he and wife Joanne founded R-Cubed Inc., an engineering firm specializing in precision measurements of optical turbulence in the atmosphere, aero-optics and efficient extraction of wind energy. He served in the United States Air Force for 30 years, retiring as a colonel. He received his doctorate degree in applied science from the University of California Davis and holds a number of patents. He is a survivor of hairy cell leukemia and currently a prostate cancer patient at MD Anderson. He is on the Intellectual Property and Technology Commercialization Advisory Group of the MD Anderson Cancer Center Board of Visitors.
Donna McNulty Reinbolt is the patient advocate for MD Anderson's lymphoma SPORE and co-founder and president of the Houston chapter of the Lymphoma Research Foundation. The National Cancer Institute selected her to serve as the national lymphoma advocate at its July 2011 Translational Science Meeting in Washington, D.C.
Ambitious fundraising effort destined to transform cancer care
It was a legendary effort. Business and community leaders in Houston, Dallas, Fort Worth and San Antonio, Texas, and in Las Vegas, Nev., raised more than $1,725,000 through four A Conversation With a Living Legend® events in Fiscal Year 2012. Over the years, the popular luncheon-interview format, which originated in Dallas in 1990 and has spread as far as Washington, D.C., and Atlanta, Ga., has raised more than $14 million for cancer research and patient care initiatives at MD Anderson.
Previous Issues
View archives
Promise Fall 2021
Walmart's support of Boot Walk benefits medical students
Summer 2021
Patient Mosaic: New pathway to precision medicine
Spring 2021
Bridge funding supports researchers amid COVID-19
Winter 2021
Companies support Blood Bank during COVID-19
Fall 2020
12-year-old osteosarcoma patient supports cancer research, spreads hope
Summer 2020
Saluting the heroes of COVID-19
Spring 2020
Rogers Award honors MD Anderson nursing assistant
Fall 2019
Fun for all at Camp H-Town
Summer 2019
MD Anderson Children’s Cancer Hospital holds Prom Party Palooza
Spring 2019
Sarah Jessica Parker shoe sale benefits prostate cancer research
Winter 2019
MD Anderson, Houston Dynamo team up to end cancer
Fall 2018
Newsmakers: Jim Allison wins Nobel Prize
Summer 2018
MD Anderson's happy campers
Spring 2018
On course with the PGA TOUR
Winter 2018
MD Anderson's Moon Shots Program turns 5
Fall 2017
Planned Giving
Summer 2017
MD Anderson Cancer Center names 2017 Sabin Family Fellows
Spring 2017
Cancer prevention efforts in full swing
Winter 2017
e-Philanthropy program raises support for patients with just a few clicks
Fall 2016
MD Anderson Cancer Center’s 75th Anniversary Celebration
Summer 2016
A win-win-win situation
Spring 2016
Until 20
Winter 2016
Global ambassadors with a collective goal
Fall 2015
25 Years of Cheer
Summer 2015
PUTTing an end to cancer
Spring 2015
A good day in cancer land
Winter 2015
Stripes aligns with MD Anderson
Fall 2014
EndTobacco
Summer 2014
Fueled by philanthropy
Spring 2014
The power of giving
Winter 2014
Washington, D.C. event honors James A. Baker, III
Fall 2013
Pedaling for a cure
Summer 2013
Lyda Hill commits $50 million to Moon Shots Program
Spring 2013
A bright future for philanthropy
Fall 2012
The time is now
Summer 2012
A leap into the future with telemedicine
Fall 2011
Data Deluge
Summer 2011
Taking a bite out of cancer: Crave Cupcakes partners with Arts in Medicine program
Spring 2011
A Global Force Against Cancer: MD Anderson Once Again Ranked No. 1
Fall 2010
Measuring Value
Summer 2010
Among Friends: Lanie Rose
Spring 2010
Making Cancer History®:
Fall 2009
Practicing the Art of the Possible
Summer 2009
Polo on the Prairie Brings World-Class Polo to West Texas
Spring 2009
The BATTLE Toward Personalized Lung Cancer Therapy